SCHEMBL1634935

SCHEMBL1634935

CC(C)NC(=O)c1ccc(Nc2ncc3ccc(-c4ccc5c(c4)CCNC5=O)cc3n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
STK17A Q9UEE5 4/20 0.50
MYLK4 Q86YV6 2/20 0.50
NEK3 P51956 1/20 0.50
LIMK1 P53667 1/20 0.50
NEK5 Q6P3R8 1/20 0.50
AURKA O14965 1/20 0.43
BRAF P15056 6/20 0.43
MAP4K1 Q92918 4/20 0.43
CDK4 P11802 1/20 0.43
CCND1 P24385 1/20 0.43
CCND3 P30281 1/20 0.43
CDK6 Q00534 1/20 0.43
PARP10 Q53GL7 1/20 0.43
PARP11 Q9NR21 1/20 0.43
RAF1 P04049 1/20 0.42
GSK3B P49841 1/20 0.42
TBK1 Q9UHD2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633639 0.88 STK17A (0.47) STK17AMYLK4NEK3LIMK1NEK5
SCHEMBL1632840 0.80 IKBKB (0.48) MAP4K1CDK4CCND1CCND3CDK6
SCHEMBL1633623 0.74 TBK1 (0.51) STK17AMYLK4NEK3LIMK1NEK5
SCHEMBL30512125 0.71 MAP4K1 (0.59) BRAFMAP4K1RAF1
SCHEMBL1632948 0.71 AURKA (0.55) STK17AMYLK4NEK3LIMK1NEK5
SCHEMBL1633340 0.71 BRAF (0.56) STK17AMYLK4NEK3LIMK1NEK5
SCHEMBL1632541 0.70 CDK4 (0.45) STK17AMYLK4CDK4CCND1CCND3
SCHEMBL1633534 0.70 AURKA (0.56) STK17AMYLK4NEK3LIMK1NEK5
SCHEMBL1633567 0.69 BRAF (0.54) STK17AMYLK4NEK3LIMK1NEK5
SCHEMBL14146531 0.69 STK17A (0.56) STK17AMYLK4NEK3LIMK1NEK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed